Skip to main content
. 2019 Jul-Aug;11(4):153–158. doi: 10.4103/ijt.ijt_43_19

Table 3.

Past medical history between those with and without a history of premature hair graying

Participant characteristics History of PHG, n (%) No history of PHG, n (%) OR (95% CI) P
Number of participants 216 251
Past medical history
 Hair loss 63 (29.2) 77 (30.7) 0.930 (0.625-1.385) 0.722
 Hypertension 28 (13.0) 38 (15.1) 0.835 (0.493-1.413) 0.501
 Hyperlipidemia 24 (11.1) 27 (10.8) 1.037 (0.579-1.857) 0.903
 Diabetes mellitus 6 (2.8) 10 (4.0) 0.689 (0.246-1.927) 0.475
 CVD 1 (0.5) 4 (1.6) 0.287 (0.032-2.589) 0.379
 Anxiety 54 (25.0) 69 (27.5) 0.879 (0.581-1.331) 0.542
 Depression 61 (28.2) 58 (23.1) 1.310 (0.863-1.987) 0.204
 Bipolar disorder 5 (2.3) 5 (2.0) 1.166 (0.333-4.082) 1.000
 Iron-deficiency anemia 35 (16.2) 32 (12.7) 1.323 (0.788-2.222) 0.288
 Pernicious anemia 1 (0.5) 0 (0.0) - 0.463
 Celiac disease 1 (0.5) 2 (0.8) 0.579 (0.052-6.430) 1.000
 Inflammatory bowel disease 1 (0.5) 5 (2.0) 0.229 (0.027-1.974) 0.224
 IBS 22 (10.2) 15 (6.0) 1.784 (0.901-3.533) 0.093
 Cystic fibrosis 0 (0.0) 1 (0.4) - 1.000
Autoimmune disease
 Systemic lupus erythematosus 0 (0.0) 3 (1.2) - 0.253
 Diabetes mellitus type 1 0 (0.0) 1 (0.4) - 1.000
 Vitiligo 0 (0.0) 0 (0.0) - -
 Hypothyroidism 15 (6.9) 14 (5.6) 1.263 (0.595-2.680) 0.542
 Hyperthyroidism 3 (1.4) 3 (1.2) 1.164 (0.233-5.829) 1.000
 Rheumatoid arthritis 3 (1.4) 0 (0.0) - 0.098

PHG – Premature hair graying; CI – Confidence interval; OR – Odds ratio; IBS – Irritable bowel syndrome; CVD – Cardiovascular disease